| For: | Izhakian S, Pertzov B, Rosengarten D, Kramer MR. Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report . World J Clin Cases 2022; 10(18): 6105-6109 [PMID: 35949821 DOI: 10.12998/wjcc.v10.i18.6105] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i18/6105.htm |
| Number | Citing Articles |
| 1 |
Daniele Previtero, Gioele Castelli, Ylenia Padrin, Francesca Scalvenzi, Isabella Ruzzon, Elisabetta Cocconcelli, Mariaenrica Tinè, Elisabetta Balestro, Roberto Padoan, Marco Caminati, Simonetta Baraldo, Paolo Spagnolo, Umberto Semenzato. Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications. European Respiratory Review 2026; 35(181) doi: 10.1183/16000617.0076-2026
|
| 2 |
Yoshiro Kai, Ryosuke Kataoka, Kentaro Suzuki, Eriko Nakamura, Masato Takano, Shigeo Muro. Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia. Respirology Case Reports 2024; 12(1) doi: 10.1002/rcr2.1279
|
| 3 |
Andrea Dionelly Murillo, Ana Isabel Castrillon, Carlos Daniel Serrano, Liliana Fernandez-Trujillo. Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review. BMC Pulmonary Medicine 2024; 24(1) doi: 10.1186/s12890-024-02868-3
|
| 4 |
Mizuki Inaba, Yasuo Shimizu, Yusuke Nakamura, Hiroaki Okutomi, Akihiro Takemasa, Seiji Niho. Tezepelumab improved chronic eosinophilic pneumonia in severe asthma patients with liver cirrhosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1381261
|
| 5 |
Luis Pérez de Llano, David Dacal Rivas, Ian Pavord, Mian Muhammad Salman Aslam, Njira Lugogo. Biologics Use in Eosinophilic Lung Disease: Controversies and Consensus. The Journal of Allergy and Clinical Immunology: In Practice 2026; 14(3) doi: 10.1016/j.jaip.2026.01.022
|